Pallavi Madhiraju
25979 posts
Pallavi has been a news reporter since 2004 writing for several websites, covering various subjects.
How Hansa Biopharma’s imlifidase could redefine access for hardest-to-match transplant candidates
Hansa Biopharma seeks FDA approval for imlifidase to expand transplant eligibility in high-risk ESRD patients. See what this filing means for U.S. access.
December 22, 2025
Pacgold (ASX: PGO) strikes high-grade antimony at St George, confirms multi-vein continuity
Pacgold's first assays at the St George Project hit up to 11.9% antimony. Find out why this matters for Australia's role in global critical minerals supply.
December 22, 2025
Rocket Lab (NASDAQ: RKLB) wins $816m U.S. Space Force contract to build missile-tracking satellites
Rocket Lab lands $816M U.S. Space Force contract to build missile-tracking satellites. Find out how this reshapes defense space strategy today.
December 21, 2025
Why is Acadia Realty Trust reshaping its finance leadership before 2026? Here is what the Buell appointment signals
Acadia Realty Trust names David Buell as Chief Accounting Officer to lead next-gen financial operations. Find out what this means for the REIT's strategy.
December 21, 2025
From Medtronic to the market: What MiniMed’s IPO means for CGM and insulin pump competition
Medtronic files IPO for MiniMed, its diabetes device business. Find out what this spin-off could mean for the future of CGM and insulin delivery tech.
December 21, 2025
From Deutsche Bank to Patria: Why Nikitas Psyllakis may redefine operational alpha
Patria Investments appoints Nikitas Psyllakis as Global COO and names new CFO in a strategic move to scale operations and expand global governance. Read more.
December 21, 2025
CTO Realty Growth (NYSE: CTO) sells Shops at Legacy North for $78m, pivots to Florida retail
CTO Realty Growth sold Shops at Legacy North for $78M to fund new acquisitions. Find out what it means for the REIT’s evolving portfolio strategy.
December 21, 2025
Will Novartis’ oral drug iptacopan change the game in myasthenia gravis treatment?
Novartis gains FDA orphan designation for iptacopan in myasthenia gravis. Explore how this oral drug could shift neurology and rare disease strategy.
December 21, 2025
Can Bill Ackman take SpaceX public on his terms and give Tesla shareholders first dibs?
Bill Ackman proposes taking SpaceX public via SPARC merger with priority access for Tesla shareholders. Find out what this bold plan really means.
December 21, 2025
Universal Studios enters Saudi Arabia: Could this be Comcast’s biggest international bet yet?
Universal Studios may build a theme park in Saudi Arabia. Find out what this means for Comcast, Saudi Vision 2030, and global entertainment strategy.
December 21, 2025